Gefapixant Citrate | m-entrepreneurship.com

Product Name :
Gefapixant Citrate

Search keywords :
Gefapixant (citrate)

drugId :
null

Target Vo:
P2X purinoceptor 3

Target Vo Short Name :
P2RX3

Moa_Name:
P2X purinoceptor 3 antagonists

First Approval Country :
Japan

First Approval Date Filter:
2022

Origin Company_Name :
F. Hoffmann-La Roche Ltd

Active Company_Name :
Merck Sharp & Dohme Bv

Active Indication_Name:
Cough

In Active Indication_Name:
Cystitis, Interstitial

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RPS6 (Y10P89) Mouse mAb Purity & Documentation
OGT Rabbit mAb medchemexpress
SOCS1 Antibody: SOCS1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 24 kDa, targeting to SOCS1. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts